Judge Won't Toss $100M Trade Secret Suit Against Akorn

Law360, New York (July 30, 2013, 7:00 PM ET) -- A New York federal judge Monday denied generic-drug maker Akorn Inc.'s argument that a $100 million trade secrets and breach of contract suit filed by Fera Pharmaceuticals LLC was barred by the companies' supply agreement, ruling the agreement might have been induced by fraud, and therefore invalid.

U.S. District Judge Louis Stanton said those provisions of the contract between Akorn and Fera, its distributor, limiting the parties’ right to sue and imposing a two-year limit on their ability to bring claims "fall with the rest of...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required